Navigating the gray zones of stroke management for a graying population

Cerebrovascular Diseases

Volumn 29, Issue 6, 2010, Pages 523-527

  Lee, Meng ^a,b   Ovbiagele, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ANTICOAGULATION; BLOOD CLOT LYSIS; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUSE OF DEATH; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE FREE SURVIVAL; DRUG SAFETY; EDITORIAL; ELDERLY CARE; HEALTH CARE DISPARITY; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; LIFE EXPECTANCY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; RISK REDUCTION; SECONDARY PREVENTION; STROKE; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; AGING; ATRIAL FIBRILLATION; CLINICAL TRIALS AS TOPIC; GUIDELINES AS TOPIC; HUMANS; HYPERTENSION; POPULATION DYNAMICS; STROKE; THROMBOLYTIC THERAPY;

EID: 77950055609     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000302737     Document Type: Editorial

References (31)

1. Sanossian N, Ovbiagele B: Prevention and management of stroke in very elderly patients. Lancet Neurol 2009; 8: 1031-1041.
2. Saposnik G, Cote R, Phillips S, et al: Stroke outcome in those over 80: a multicenter cohort study across Canada. Stroke 2008; 39: 2310-2317.
3. Marini C, Baldassarre M, Russo T, et al: Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology 2004; 62: 77-81.
4. Hodgson TA, Cohen AJ: Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures. Med Care 1999; 37: 994-1012.
5. Kaplan RC, Tirschwell DL, Longstreth WT Jr, et al: Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology 2005; 65: 835-842.
6. Palnum KD, Petersen P, Sorensen HT, et al: Older patients with acute stroke in Denmark: quality of care and short-term mortality - a nationwide follow-up study. Age Ageing 2008; 37: 90-95.
7. Moroney JT, Tseng CL, Paik MC, Mohr JP, Desmond DW: Treatment for the secondary prevention of stroke in older patients: the influence of dementia status. J Am Geriatr Soc 1999; 47: 824-829.
8. Stroke Unit Trialists' Collaboration: Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007; 4:CD000197. DOI: 000110.001002/14651858. CD14000197.pub14651852.
9. Bushnell CD, Colon-Emeric CS: Secondary stroke prevention strategies for the oldest patients: possibilities and challenges. Drugs Aging 2009; 26: 209-230.
10. Mant J, Hobbs FD, Fletcher K, et al: Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503. (Pubitemid 47212371)
11. Connolly SJ, Ezekowitz MD, Yusuf S, et al: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
12. Weycker D, Edelsberg J, Vincze G, Levy DG, Kartashov A, Oster G: Blood pressure control in patients initiating antihypertensive therapy. Ann Pharmacother 2008; 42: 169-176.
13. Beckett NS, Peters R, Fletcher AE, et al: Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.
14. Systolic Hypertension in the Elderly Program Cooperative Research Group: Implications of the systolic hypertension in the elderly program. Hypertension 1993; 21: 335-343.
15. Staessen JA, Fagard R, Thijs L, et al: Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med 1998; 158: 1681-1691.
16. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
17. Lithell H, Hansson L, Skoog I, et al: The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-886. (Pubitemid 36677151)
18. Gianni M, Bosch J, Pogue J, et al: Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients. Eur Heart J 2007; 28: 1382-1388.
19. Engelter ST, Bonati LH, Lyrer PA: Intravenous thrombolysis in stroke patients of 6 80 versus ! 80 years of age - a systematic review across cohort studies. Age Ageing 2006; 35: 572-580.
20. Chen CI, Iguchi Y, Grotta JC, et al: Intravenous TPA for very old stroke patients. Eur Neurol 2005; 54: 140-144.
21. Berrouschot J, Rother J, Glahn J, Kucinski T, Fiehler J, Thomalla G: Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old ( 6 80 years) stroke patients. Stroke 2005; 36: 2421-2425.
22. Engelter ST, Reichhart M, Sekoranja L, Georgiadis D, Baumann A, Weder B, Müller F, Lüthy R, Arnold M, Michel P, Mattle HP, Tettenborn B, Hungerbühler HJ, Baumgartner RW, Sztajzel R, Bogousslavsky J, Lyrer PA: Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 2005;65:1795-1798.
23. Sylaja PN, Cote R, Buchan AM, Hill MD: Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 2006; 77: 826-829.
24. Meseguer E, Labreuche J, Olivot JM, et al: Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review. Age Ageing 2008; 37: 107-111.
25. Tanne D, Gorman MJ, Bates VE, et al: Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke 2000; 31: 370-375.
26. Van Oostenbrugge RJ, Hupperts RM, Lodder J: Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre. J Neurol Neurosurg Psychiatry 2006; 77: 375-377.
27. Kim D, Ford GA, Kidwell CS, et al. Intra-arterial thrombolysis for acute stroke in patients and older: a comparison of results in patients younger than 80 years. AJNR Am J Neuroradiol 2007; 28: 159-163
28. Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD: Acute stroke management in the elderly. Cerebrovasc Dis 2007; 23: 304-308.
29. Williams MA, Fleg JL, Ades PA, et al: Secondary prevention of coronary heart disease in the elderly (with emphasis on patients 6 75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002; 105: 1735-1743.
30. Ovbiagele B: Pessin award lecture 2008: lessons from the Stroke PROTECT program. J Neurol Sci 2008; 275: 1-6.
31. Kriekard P, Gharacholou SM, Peterson ED: Primary and secondary prevention of cardiovascular disease in older adults: a status report. Clin Geriatr Med 2009; 25: 745-755, x.